Cliff Asness's ELDN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 172,417 shares of Eledon Pharmaceuticals, Inc. (ELDN) worth $531,045, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in ELDN, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 112,202 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Eledon Pharmaceuticals (ELDN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eledon Pharmaceuticals (ELDN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +112,202 | Add 186.34% | 172,417 | $3.08 |
| Q4 2025 | +60,215 | New Buy | 60,215 | $1.51 |
Cliff Asness's Eledon Pharmaceuticals Investment FAQs
Cliff Asness first purchased Eledon Pharmaceuticals, Inc. (ELDN) in Q4 2025, acquiring 60,215 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Eledon Pharmaceuticals, Inc. (ELDN) for 2 quarters since Q4 2025.
Cliff Asness's largest addition to Eledon Pharmaceuticals, Inc. (ELDN) was in Q1 2026, adding 172,417 shares worth $531,045.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 172,417 shares of Eledon Pharmaceuticals, Inc. (ELDN), valued at approximately $531,045.
As of the Q1 2026 filing, Eledon Pharmaceuticals, Inc. (ELDN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Eledon Pharmaceuticals, Inc. (ELDN) was 172,417 shares, as reported at the end of Q1 2026.